These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 25092265)

  • 1. The validation of the 2010 American Association for the Study of Liver Diseases guideline for the diagnosis of hepatocellular carcinoma in an endemic area.
    Lin MT; Chang KC; Chou YP; Tseng PL; Yen YH; Wang CC; Tsai MC; Cheng YF; Eng HL; Wu CK; Hu TH
    J Gastroenterol Hepatol; 2015 Feb; 30(2):345-51. PubMed ID: 25092265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic sensitivity of hepatocellular carcinoma imaging and its application to non-cirrhotic patients.
    Lin MT; Chen CL; Wang CC; Cheng YF; Eng HL; Wang JH; Chiu KW; Lee CM; Hu TH
    J Gastroenterol Hepatol; 2011 Apr; 26(4):745-50. PubMed ID: 21418303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hepatocellular carcinoma with cirrhosis patients undergoing hepatic resection between hepatitis B and C infection.
    Shiba H; Ishida Y; Fujiwara Y; Wakiyama S; Gocho T; Ito R; lida T; Suzuki F; Furukawa K; Haruki K; Misawa T; Yanaga K
    Hepatogastroenterology; 2013 Oct; 60(127):1746-8. PubMed ID: 24634946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area.
    Bae SY; Choi MS; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Yoo BC
    Clin Mol Hepatol; 2012 Jun; 18(2):185-94. PubMed ID: 22893869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of clinical criteria for the diagnosis of hepatocellular carcinoma without biopsy in a Hepatitis B virus-endemic area.
    Park JW; An M; Choi JI; Kim YI; Kim SH; Lee WJ; Park SJ; Hong EK; Kim CM
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):937-43. PubMed ID: 17516087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.
    Van Roey G; Fevery J; Van Steenbergen W
    Eur J Gastroenterol Hepatol; 2000 Jan; 12(1):61-6. PubMed ID: 10656212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive diagnostic criteria for hepatocellular carcinoma in hepatic masses >2 cm in a hepatitis B virus-endemic area.
    Kim SE; Lee HC; Shim JH; Park HJ; Kim KM; Kim PN; Shin YM; Yu ES; Chung YH; Suh DJ
    Liver Int; 2011 Nov; 31(10):1468-76. PubMed ID: 21745284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiological, clinical and therapeutic features of hepatocellular carcinoma in cirrhotic patients].
    Said Y; Debbeche R; Ben Ali Z; Bouzid K; Trabelsi S; Bouzaidi S; Salem M; Rajhi H; Kouni Chahed M; Najjar T
    Tunis Med; 2012 Jun; 90(6):468-72. PubMed ID: 22693088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
    Wang Q; Luan W; Villanueva GA; Rahbari NN; Yee HT; Manizate F; Hiotis SP
    J Dig Dis; 2012 Apr; 13(4):214-8. PubMed ID: 22435506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Invasive Diagnostic Criteria for Hepatocellular Carcinoma in Hepatitis B Virus-Endemic Areas: Is Cirrhosis Indispensable?
    Huang XW; Liao B; Huang Y; Liang JY; Shan QY; Shen SL; Xie XY; Lu MD; Chen LD; Wang W
    Dig Dis; 2018; 36(3):228-235. PubMed ID: 29353268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies.
    Willatt JM; Hussain HK; Adusumilli S; Marrero JA
    Radiology; 2008 May; 247(2):311-30. PubMed ID: 18430871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines.
    Furlan A; Marin D; Cabassa P; Taibbi A; Brunelli E; Agnello F; Lagalla R; Brancatelli G
    Eur J Radiol; 2012 Sep; 81(9):2099-105. PubMed ID: 21906896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
    Lewin M; Gelu-Simeon M; Ostos M; Boufassa F; Sobesky R; Teicher E; Meyer L; Fontaine H; Salmon-Céron D; Samuel D; Seror O; Trinchet JC; Duclos-Vallée JC
    Radiology; 2015 Nov; 277(2):443-53. PubMed ID: 25961631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The applicability of hepatocellular carcinoma risk prediction scores in a North American patient population with chronic hepatitis B infection.
    Abu-Amara M; Cerocchi O; Malhi G; Sharma S; Yim C; Shah H; Wong DK; Janssen HL; Feld JJ
    Gut; 2016 Aug; 65(8):1347-58. PubMed ID: 25934760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen].
    Ouedraogo W; Tran-Van Nhieu J; Baranes L; Lin SJ; Decaens T; Laurent A; Djabbari M; Pigneur F; Duvoux C; Kobeiter H; Deux JF; Rahmouni A; Luciani A
    J Radiol; 2011; 92(7-8):688-700. PubMed ID: 21819911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver.
    Kim JM; Kwon CH; Joh JW; Park JB; Lee JH; Kim SJ; Paik SW; Park CK; Yoo BC
    J Surg Oncol; 2014 Dec; 110(8):976-81. PubMed ID: 25171344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma.
    Manini MA; Sangiovanni A; Fornari F; Piscaglia F; Biolato M; Fanigliulo L; Ravaldi E; Grieco A; Colombo M;
    J Hepatol; 2014 May; 60(5):995-1001. PubMed ID: 24462368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.